Mark Deboer, MD
Enriched profileAssociate Professor, Department of Pediatrics · University of Virginia
Mark Deboer is Associate Professor, Department of Pediatrics at University of Virginia. OpenAlex indexes 251 publications with 11,539 citations (h-index 59); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Endocrinology profiles in the findmyKOL directory.
Data verified 13 Oct 2026
Overview
Updated 14 Oct 2026
Mark Deboer, MD, is Associate Professor, Department of Pediatrics at University of Virginia. The public record shows 251 publications with 11,539 citations (h-index 59), centered on Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Education. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 2 companies, 7 NIH-funded awards (2008–2026).
- Most recent indexed publication: 2026 · Science (New York, N.Y.)
- Top research focus: Diabetes Management and Research
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 156.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 14 Oct 2026
2 companies reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
- Tandem Diabetes Care, Inc.Program year20251 payment
NIH funding
Updated 14 Oct 2026
7 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- Limiting Dysglycemia Around Physical Activity for People with Type 1 Diabetes Using Activity-Aware Automated Insulin Delivery – the APEX Project.
University of Virginia
FY2026$660,262R01DK139065 - Limiting Dysglycemia Around Physical Activity for People with Type 1 Diabetes Using Activity-Aware Automated Insulin Delivery – the APEX Project.
University of Virginia
FY2025$673,151R01DK139065 - Limiting Dysglycemia Around Physical Activity for People with Type 1 Diabetes Using Activity-Aware Automated Insulin Delivery – the APEX Project.
University of Virginia
FY2024$686,100R01DK139065
Congress activity
Updated 14 Oct 2026
18 congress contributions (2018–2025) across ADA, ENDO per OpenAlex. The most recent:
- 653-P: Psychosocial Factors and Technology Perceptions Are Associated with Glycemic Outcomes in Fully Closed Loop Systems (FCL)
ADA Scientific Sessions
ADA2025Co-authorPoster - 928-P: AI-Based Fully Closed Loop (FCL) Achieves Improved Glycemia vs. Hybrid Closed Loop (HCL) in People with Type 1 Diabetes (T1D)
ADA Scientific Sessions
ADA2025Co-authorPoster - 190-LB: Differences in Postprandial and Counterregulatory Glucagon Excursions in Healthy Relatives to Type 1 Diabetes with Different Number of Islet Autoantibodies
ADA Scientific Sessions
ADA2023Co-authorLate-breaking
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Shared patterns of human milk composition link mammary gland function to infant growth.
Science (New York, N.Y.)
Article2026 - Growth and cognition over eight years in three sites of the MAL-ED cohort study.
PLOS global public health
Article2026 - Free testosterone independently predicts metabolic syndrome severity in U.S. adolescent girls aged 12-19 years.
Journal of the Endocrine Society
Article2026 - The Rise and Rise of Type 1 and Type 2 Diabetes in Youth.
Diabetes, metabolic syndrome and obesity
Review2025
Most-cited works
by citation count (OpenAlex)- 01The impoverished gut—a triple burden of diarrhoea, stunting and chronic diseaseReview602 citations2012
- 02A Randomized Trial of Closed-Loop Control in Children with Type 1 DiabetesArticle450 citations2020
- 03Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent ExacerbationsArticle435 citations2016
- 04Intermittent Fasting and Metabolic HealthArticle284 citations2022
- 05Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with AgeArticle280 citations2017
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →childrens.uvahealth.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.virginia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.virginia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →childrens.uvahealth.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →childrens.uvahealth.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.med.virginia.edu ↗
Media & interviews
press, podcasts and appearances- Featured researcher in University of Virginia School of Medicine Research in Motion video series discussing diabetes
metabolic syndrome, and growth challenges in pediatric populations
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Lobo, MD
University of Virginia
Charles Landen, MD
University of Virginia
Stephen Caldwell
University of Virginia
James Platts-Mills, MD
University of Virginia
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine